Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of molecular medicine

• Publication date

  2005-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00109-004-0600-xPMID 15723265
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is aspirin resistance a real problem in people with type 2 diabetes?

  2004cited by this paper
• Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control.

  2004influential reference
• Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.

  2003cited by this paper
• Is platelet aggregation a more important contributor than platelet adhesion to the overall platelet-related primary haemostasis measured by PFA-100?

  2003cited by this paper
• Platelet responsiveness to aspirin in patients with hyperlipidaemia

  2003cited by this paper
• The platelet in diabetes: focus on prevention of ischemic events.

  2003cited by this paper
• Research pointers: Platelet responsiveness to aspirin in patients with hyperlipidaemia.

  2003cited by this paper
• Aspirin resistance: definition, mechanisms and clinical read‐outs

  2003cited by this paper
• A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease.

  2003cited by this paper
• Polymorphisms of glycoprotein Ib affect the inhibition by aurintricarboxylic acid of the von Willebrand factor dependent platelet aggregation

  2002cited by this paper
• Enhancing effect of advanced glycation end products on serotonin-induced platelet aggregation in patients with diabetes mellitus.

  2002cited by this paper
• Aspirin Resistance in Cardiovascular Disease: A Review of Prevalence, Mechanisms, and Clinical Significance

  2002cited by this paper
• Possible Mechanisms of Aspirin Resistance

  2002cited by this paper
• Platelet hyperactivity and abnormal Ca(2+) homeostasis in diabetes mellitus.

  2001cited by this paper
• Effects of fibrinogen receptor antagonist GR144053F and aurintricarboxylic acid on platelet activation and degranulation.

  2001cited by this paper
• Profile and prevalence of aspirin resistance in patients with cardiovascular disease.

  2001cited by this paper
• SELECTIVE CHEMILUMINESCENCE ANALYSIS OF AMADORI FORM OF GLYCATED HUMAN SERUM ALBUMIN

  2000cited by this paper
• In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

  1999cited by this paper
• Acetyl- L -carnitine decreases glycation of lens proteins: in vitro studies.

  1999cited by this paper
• Possible mechanisms of the altered platelet volume distribution in type 2 diabetes: does increased platelet activation contribute to platelet size heterogeneity?

  1999influential reference
• In Vivo Formation of 8-Iso-Prostaglandin F2α and Platelet Activation in Diabetes Mellitus

  1999cited by this paper
• PFA-100™ System: A New Method for Assessment of Platelet Dysfunction

  1998cited by this paper
• Effect of aspirin and sodium salicylate on cataract development in diabetic rats.

  1998cited by this paper
• Aspirin Therapy in Diabetes

  1998cited by this paper
• Fibrin gel structure in diabetic patients before and during treatment with acetylsalicylic acid: a pilot study

  1998cited by this paper
• Aspirin Therapy in Diabetes

  1997cited by this paper
• Effects of Aspirin or Basic Amino Acids on Collagen Cross-Links and Complications in NIDDM

  1997influential reference
• Fluorimetric Determination of Tissue Distribution and Differences Between the Activity of Aspirin Esterases I and II in Mice and Rats

  1997cited by this paper
• The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase

  1995cited by this paper
• Platelets, vascular disease, and diabetes mellitus.

  1994cited by this paper
• Relationship of platelet aggregation to bleeding after cardiopulmonary bypass.

  1994influential reference
• The inhibition of sugar-induced structural alterations in collagen by aspirin and other compounds.

  1994influential reference
• Quantitation of epsilon-amino group using amino acids as reference standards by trinitrobenzene sulfonic acid. A simple spectrophotometric method for the estimation of hapten to carrier protein ratio.

  1994cited by this paper
• Glycation of human lens crystallins: effect of age and aspirin treatment.

  1993cited by this paper
• Effect of aspirin on conformation and dynamics of membrane proteins in platelets and erythrocytes.

  1993cited by this paper
• Influence of aspirin on human megakaryocyte prostaglandin synthesis

  1993cited by this paper
• Decreased Platelet Membrane Fluidity Due to Glycation or Acetylation of Membrane Proteins

  1992cited by this paper
• Differential Effect of Aspirin on Platelet Aggregation in IDDM

  1992cited by this paper
• European Stroke Prevention Study: Effectiveness of Antiplatelet Therapy in Diabetic Patients in Secondary Prevention of Stroke

  1992cited by this paper
• Large Platelets Circulate in an Activated State in Diabetes Mellitus

  1991cited by this paper
• Inhibition of lens crystallin glycation and high molecular weight aggregate formation by aspirin in vitro and in vivo.

  1989cited by this paper
• Rapid photometric method for estimation of platelet count in blood plasma or platelet suspension.

  1989cited by this paper
• Non-enzymatic acetylation of proteins by aspirin as protection against the secondary complications of diabetes mellitus.

  1986cited by this paper
• Inhibition of glycation of albumin and hemoglobin by acetylation in vitro and in vivo.

  1986cited by this paper
• Trial of repeated low-dose aspirin in diabetic angiopathy.

  1986cited by this paper
• Measurement of protein using bicinchoninic acid.

  1985cited by this paper
• Fluorescent triplet probes for measuring the rotational diffusion of membrane proteins.

  1982cited by this paper
• Factor-VIII-related antigen: measurement by enzyme immunoassay.

  1976cited by this paper

• Prevention of unfavorable fibrin clots and thrombo-embolic manifestations in patients with cardiovascular disease

  2025cites this paper
• Post-translational modifications of fibrinogen: implications for clotting, fibrin structure and degradation

  2024cites this paper
• Protein posttranslational modifications in metabolic diseases: basic concepts and targeted therapies

  2024cites this paper
• IMPACT OF GESTATIONAL DIABETES MELLITUS ON HEMATOLOGICAL PARAMETERS, LIVER FUNCTION, RENAL FUNCTION, AND LIPID PROFILE IN ANTENATAL WOMEN AT A TERTIARY CARE HOSPITAL

  2024cites this paper
• Biomimetic Platelet Nanomotors for Site-Specific Thrombolysis and Ischemic Injury Alleviation.

  2023cites this paper
• Antithrombotic therapy in patients with diabetes mellitus

  2023cites this paper
• Effect of oral versus parenteral vitamin D3 supplementation on nuclear factor-κB and platelet aggregation in type 2 diabetic patients.

  2023cites this paper
• The amino acid content in the daily diet of seniors negatively correlates with the degree of platelet aggregation in a sex- and agonist-specific manner

  2022cites this paper
• Plasma Concentration of Cortisol Negatively Associates with Platelet Reactivity in Older Subjects

  2022cites this paper
• The Association between Glycosylated Hemoglobin Level and Platelets Reactivity in Patients with Diabetes Mellitus Undergoing Elective Coronary Artery Bypass Grafting

  2021cites this paper
• A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control

  2021cites this paper
• Association of Long-term Use of Low-Dose Aspirin as Chemoprevention With Risk of Lung Cancer

  2019cites this paper
• The Role of Platelets in Diabetes Mellitus

  2019cites this paper
• A high glucose level is associated with decreased aspirin-mediated acetylation of platelet cyclooxygenase (COX)-1 at serine 529: A pilot study.

  2019cites this paper
• The role of resistance to acetylsalicylic acid in patients with ischemic stroke

  2019cites this paper
• Determinants of aspirin resistance in patients with type 2 diabetes.

  2019cites this paper
• DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome

  2019cites this paper
• Mutli-Features Prediction of Protein Translational Modification Sites

  2018cites this paper
• A comparative proteomic and glycoproteomic study of platelets from patients with diabetes and non-diabetic healthy individuals

  2018cites this paper
• Glycation, oxidation and glycoxidation of IgG: a biophysical, biochemical, immunological and hematological study

  2018cites this paper
• Chapter 9 Mechanisms Involved in Diabetes-Associated Platelet Hyperactivation

  2018cites this paper
• B β Arg 448 Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes

  2018cites this paper
• BArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes

  2018cites this paper
• Aspirin for primary prevention of cardiovascular and all‐cause mortality events in diabetes: updated meta‐analysis of randomized controlled trials

  2017cites this paper
• Carbamylation is a competitor of glycation for protein modification in vivo.

  2017cites this paper
• Association of Complete Blood Count Parameters with Gestational Diabetes Mellitus

  2017cites this paper
• Mechanisms of Platelet Activation in Diabetes Mellitus

  2017cites this paper
• Effects of kisspeptin on diabetic rat platelets.

  2017cites this paper
• Aspirin in the prevention of cardiovascular events in patients with diabetes

  2016cites this paper
• Non-enzymatic modifications of prostaglandin H synthase 1 affect bifunctional enzyme activity - Implications for the sensitivity of blood platelets to acetylsalicylic acid.

  2016cites this paper
• FREQUENCY OF ASPIRIN RESISTANCE IN PATIENTS WITH TYPE 1 AND 2 DIABETES MELLITUS AND ITS ASSOCIATION WITH METABOLIC PARAMETERS

  2016cites this paper
• BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes

  2016cites this paper
• Treatment Goals in Diabetes.

  2016cites this paper
• Oporność na leki przeciwpłytkowe : przyczyny i możliwości diagnostyki

  2016cites this paper
• Synergistic and inhibitory effects of propolis and aspirin on structural changes of human hemoglobin resulting from glycation: an in vitro study

  2016cites this paper
• The prognostic utility of tests of platelet function for the detection of 'aspirin resistance' in patients with established cardiovascular or cerebrovascular disease: a systematic review and economic evaluation.

  2015cites this paper
• Aspirin for primary prevention in diabetes mellitus: from the calculation of cardiovascular risk and risk/benefit profile to personalised treatment

  2015cites this paper
• Platelets and diabetes mellitus.

  2015cites this paper
• The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with Aspirin

  2015cites this paper
• Mechanisms Involved in Diabetes-Associated Platelet Hyperactivation

  2015cites this paper
• Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus.

  2015cites this paper
• Aspirin resistance in patients with type II diabetes mellitus

  2014cites this paper
• Aktuelles: Management des Diabetes-ACS-Patienten mit Prasugrel

  2014cites this paper
• Aspirin Half Maximal Inhibitory Concentration Value on Platelet Cyclooxygenase1 in Severe Type-2 Diabetes Mellitus is not Significantly Different from that of Healthy Individuals

  2014influential citation
• Elevated mean platelet volume is associated with gestational diabetes mellitus

  2014cites this paper
• Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study

  2014cites this paper
• Glükoosi pidurdav toime trombotsüütide agregatsiooni inhibeerimisele COXi inhibiitorite ja L-arginiiniga in vitro

  2014cites this paper
• Hypertension as a Risk Factor for Aspirin and Clopidogrel Resistance in Patients With Stable Coronary Artery Disease

  2014cites this paper
• Impact of high glucose concentration on aspirin-induced acetylation of human serum albumin: An in vitro study

  2014cites this paper
• Mechanistic studies on human fibrinogen polymorphisms that influence blood clot formation and lysis

  2013cites this paper
• Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.

  2013cites this paper
• Efficacy of Antiplatelet Treatment in Stroke Prevention: Past, Present, and Future

  2013cites this paper
• Chapter 35 – Diabetes Mellitus

  2013cites this paper
• OCENA OPORNO ŚCI NA SKOJARZONE LECZENIE PRZECIWPËYTKOWE U CHORYCH Z TROPONINODODATNIM OSTRYM ZESPOËEM WIE ŃCOWYM LECZONYCH INWAZYJNIE

  2013cites this paper
• KORONER ARTER HASTALIĞI YAYGINLIĞI VE TEKRARLAYAN PERKÜTAN KORONER GİRİŞİMLER ARASINDAKİ İLİŞKİ

  2013cites this paper
• In-vitro-Effekt von Hydroxyethylstärke 130/0,42 auf die canine Thrombozytenfunktion

  2013cites this paper
• Aspirin Dose Increase from 75 to 150 mg Suppresses Red Blood Cell Contribution to Suboptimal Platelet Response to Aspirin in Patients with CAD

  2013cites this paper
• Aspirin in Type 2 Diabetes: A survey of prescribing habits and Investigation of effects on Inflammation, Oxidative stress, Insulin Resistance and Endothelial Function.

  2012cites this paper
• Increased Atherothrombotic Burden in Patients with Diabetes Mellitus and Acute Coronary Syndrome: A Review of Antiplatelet Therapy

  2012cites this paper
• Pravastatin and simvastatin improves acetylsalicylic acid‐mediated in vitro blood platelet inhibition

  2012cites this paper
• Approaches to Prevention of Cardiovascular Complications and Events in Diabetes Mellitus

  2012cites this paper
• Antiplatelet therapy in patients with diabetes mellitus.

  2012cites this paper
• Aspirin Resistance: Current Status and Role of Tailored Therapy

  2012cites this paper
• Aspirin resistance, platelet turnover, and diabetic angiopathy: a 2011 update.

  2012cites this paper
• Antiplatelet effect of aspirin in patients with coronary artery disease.

  2012cites this paper
• Acetylation and glycation of fibrinogen in vitro occur at specific lysine residues in a concentration dependent manner: a mass spectrometric and isotope labeling study.

  2012cites this paper
• High-Dose Aspirin Is Required to Influence Plasma Fibrin Network Structure in Patients With Type 1 Diabetes

  2012cites this paper
• Variability in the response to antiplatelet treatment in diabetes mellitus.

  2012cites this paper
• Advances in monitoring of aspirin therapy

  2012cites this paper
• Aspirin resistance in patients with acute ischemic stroke

  2011cites this paper
• The effect of a platelet cholesterol modulation on the acetylsalicylic acid-mediated blood platelet inhibition in hypercholesterolemic patients.

  2011cites this paper
• Current concepts on coronary revascularization in diabetic patients.

  2011cites this paper
• Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis

  2011cites this paper
• Antiplatelet resistance in stroke

  2011cites this paper
• Diabetes Mellitus and Cardiovascular Prevention: The Role and the Limitations of Currently Available Antiplatelet Drugs

  2011cites this paper
• Tackling the thrombotic burden in patients with acute coronary syndrome and diabetes mellitus

  2011cites this paper
• Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome

  2011cites this paper
• Aspirin resistance in patients with chronic renal failure.

  2011cites this paper
• TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus

  2011cites this paper
• The potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury

  2011cites this paper
• Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors

  2011cites this paper
• Glycated collagen alters endothelial cell actin alignment and nitric oxide release in response to fluid shear stress.

  2011cites this paper
• Aspirin resistance: effect of clinical, biochemical and genetic factors.

  2011cites this paper
• “PROFILING OF THE PLATELET PROTEINS IN ATHEROSCLEROSIS RISK FACTOR GROUP: A COMPARATIVE ANALYSIS.” A DISSERTATION SUBMITTED BY Binnu Gangadharan IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF PHILOSOPHY SREE CHITRA TIRUNAL INSTITUTE FORMEDICAL

  2011cites this paper
• PLATELET AGGREGATION AND SERUM THROMBOXANE B2 LEVEL AFTER TAKING 60 MG/DAY OF ASPIRIN IN TYPE 2 DIABETIC THAI PATIENTS

  2011cites this paper
• Diabetes and Cardiovascular Disease Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome

  2011cites this paper
• This material is the copyright of the original publisher. Unauthorised copying and distribution is prohibited. Antiplatelet Drugs - Do We Need New Options? With a Reappraisal of Direct Thromboxane Inhibitors

  2010cites this paper
• Effect of antioxidant vitamin supplementation on erythrocyte membrane composition in Type I diabetes mellitus in context of oxidative stress

  2010cites this paper
• Old and New Molecular Mechanisms Associated with Platelet Resistance to Antithrombotics

  2010cites this paper
• Antiplatelet Drugs — Do We Need New Options?

  2010cites this paper
• Aspirin Resistance in Hypertensive Patients

  2010cites this paper
• Aspirin as antiplatelet agent in diabetes. PROS-.

  2010cites this paper
• Étude de l’effet des médicaments antiplaquettaires sur la fonction plaquettaire : de la variabilité de réponse à l’effet rebond

  2010cites this paper
• Profiling Of The Platelet Proteins In Atherosclerosis Risk Factor Group: A Comparative Analysis

  2010cites this paper
• Inhibition of platelet GPIIb-IIIa and P-selectin expression by aspirin is impaired by stress hyperglycemia.

  2009cites this paper
• ariabilité de réponse plaquettaire à l’aspirine et ouvelles cibles thérapeutiques ariable platelet response to aspirin and new herapeutic targets

  2009cites this paper
• Responsiveness to aspirin in patients with unstable angina pectoris by whole blood aggregometry

  2009cites this paper
• Resorcylidene aminoguanidine induces antithrombotic action that is not dependent on its antiglycation activity.

  2009cites this paper
• Structure, stability, and antiplatelet activity of O-acyl derivatives of salicylic acid and lipophilic esters of acetylsalicylate

  2009cites this paper
• Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current Treatment Strategies and Future Directions

  2009cites this paper